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Abstract. mAbs have been raised against different
epitopes on the protein product of the DMDL gene,
which is an autosomal homologue of the X-linked
DMD gene for dystrophin. These antibodies provide
direct evidence that DMDL protein is localized near
acetylcholine receptors at neuromuscular junctions in
normal and nzdx mouse intercostal muscle. The pri-
mary location in tissues other than skeletal muscle
is smooth muscle, especially in the vascular system,
which may account for the wide tissue distribution
previously demonstrated by Westem blotting. The
N autosomal homologue (DMDL) of the dystrophin
gene is found on chromosome 6 in man (10) and
close to the dystrophia muscularis (dy) locus on
chromosome 10 in the mouse (2). Unlike dystrophin, which
is expressed predominantly in muscle tissues and localized
at the sarcolemma (5), the DMDLprotein is foundin varying
amounts in most tissues (7, 11) and its subcellular location
has not yet been defined. The homologue belongs to a family
of related proteins, which include dystrophin, spectrin and
actinin (9), as well as possible protein products ofalternative
COON-terminal transcripts ofthe dystrophin gene (1). Anti-
body cross-reactions can occurwithin the family, complicat-
ing the interpretation of immunolocalization results (13).
This problem has been largely avoided in the case of dystro-
phin by taking advantage of null mutations in the dystrophin
gene in Duchenne muscular dystrophy patients and the mdx
mouse. Without a specific mutation which eliminates the
DMDL gene product, the use of a number of different epi-
tope-specific mAbs for immunostaining offers the best ap-
proach to tissue and subcellular localization of authentic
DMDL protein.
The preparation of 19 dystrophin-specific mAbs using, as
immunogen, a pEX2 bacterial fusion protein (lacZ-108kD)
containingnearly halfof the central helical sequence of dys-
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DMDL protein was undetectable in the nonjunctional
sarcolemma of normal human muscle, but was ob-
served in nonjunctional sarcolemma of Duchenne mus-
cular dystrophy patients, where dystrophin itself is
absent or greatly reduced. The expression of DMDL
protein is not restricted to smooth and skeletal mus-
cle, however, since relatively large amounts are pres-
ent in transformed brain cell lines of both glial and
Schwann cell origin. This contrasts with the low levels
of DMDL protein in adult brain tissue.
trophin has already been described (12) . We now report the
preparation of 19 new mAbs against a pEX2 fusion protein
(lacZ-Bfin3) containing the last 329 amino-acids of the
DMDL protein (10, 11) and their use in the localization of
DMDL protein in normal and dystrophic muscle and in non-
muscle tissues.
Materials andMethods
mAb Production
The expression plasmid was produced by cloning a 1.05-kb fragment of
Bfm3 cDNA (10, 11) into the SmaI site of pEX2. The fragment starts at
nucleotide 510 in the sequence (10) and the plasmid was introduced into
E. coli POP2136. Induction by incubation at 42°C and purification of the
155-kD fl-galactosidase fusion protein by extraction of inclusion bodies
with 2 % SDS and gel filtration on UltragelAcA34 (LKB Instruments, Inc.,
Gaithersburg, MD) were performed as described previously (12). mAbs
were produced by immunization of Balb/c mice and fusion of spleen cells
with Sp2/0 myeloma cells as described previously (12). Hybridoma cul-
ture supernatants were screened initially by ELISA using microtiter plates
coated with fusion protein or with S-galactosidase alone and were further
selected for binding to a 400-kD protein on Western blots of human lung
extracts. All hybridomacell lines were subclonedtwiceby limiting dilution.
The immunoglobulin subtypeof each antibody was determined with an iso-
typing kit (Serotec, Oxford, UK).Rat Cell Lines
The C6 rat glial tumour cell line (ATCC No. CCL107) and the SWA trans-
formed ratSchwann cell line (18) were growninculture dishesin DME with
10% FCS and, for SWA cells, 0.1 MM ZnC12.
Western Blotting
Freshly dissected mouse or frozen human tissues were weighed, dropped
into 4 ml/g of boiling SDS extraction buffer (10% SDS, 10% EDTA, 10%
glycerol, 5% 2-mercaptoethanol, 50 mM Tris-HCI, pH 6.7), homogenized
witha Silverson blender, boiled for2 min, andcentrifugal at 100,000 g for
20 min. This procedure produces extracts containing approximately the
same concentration of total protein for all tissues studied. Cultured cells
were harvested in sample buffer containing 2% SDS and 5% 2-mercapto-
ethanol, boiled, andcentrifugal. Extracts(10Al) were loadedonto 4-12.5%
gradientgelswith a4% stacking gel, togetherwith 5 Al ofprestainedmolec-
ular mass markers (Sigma Chemical Co., St. Louis, MO; 180, 116, 84, 58,
48.5, 36.5, and26.6 kD; l mg/ml each). Afterelectrophoresis, proteins were
transferred electrophoretically (Bioltad Transblot; Bio-ltad Laboratories,
Cambridge, MA) to nitrocellulose sheets (Schleicher and Schull, BA85) at
100 mAovernight in 25 mM Tris, 192 mM glycine, 0.003% SDS. The SDS
concentration is critical and must be adjusted to the minimum required for
efficient transfer of very high M, proteins.
Blots were blocked in 3 % skimmed milk powder in incubation buffer
(0.05% Triton X-100 in PBS 25 mM sodium phosphate, pH 7.2, 0.9%
NaCl). After two 5-minwashes inPBS, blots were incubated withmAb cul-
ture supernatant (1/100 dilution in incubation buffer/1% horse serum/1%
FCS/0.3% BSA) for 1 h at 20°C. After three 5-min washes with PBS, blots
were incubatedwith biotinylated anti-mouse Ig and a peroxidase-avidin de-
tection reagent (Vectastain ABC kit), according to the manufacturer's in-
structions (Vector Laboratories, Peterborough, UK). After four 5-min
washes withPBS, substrate was added (0.4mg/ml diaminobenzidine (Sigma
Chemical Co.) in 25 mM phosphate-citrate buffer, pH 5.0, with 0.012%
H202).
To screen a single sample with a large number ofantibodies (up to 28),
extracts weresubjected to SDS-PAGEas astrip (250 AI), anda"miniblotter"
apparatus (Immunetics, Cambridge, MA) was used to apply the mAbs as
vertical lanes across all the protein bands on the blot.
Immunohistochemistry
Frozen sections (7-10 Am) ofhuman and mouse tissues were allowed to at-
tach to untreated glass slides and either stored at -80°C or fixed with ace-
tone and air-dried. After incubation for 30 min at 20°C with mAb culture
supernatants, diluted 1+3 with PBS, andthree 5-min washes withPBS, sec-
tions were incubated with second antibody for 30 min at 20°C. The second
antibody (DAKOpatts Ltd; 1/40 dilution in PBS containing 1% horse se-
rumll% FCS/0.3% BSA)was anti-mouse Ig labeledwith fluoresceinor per-
oxidase. For double labeling, fluorescein-labeled a-bungarotoxin (Sigma
Chemical Co. ; 10 Ag/ml) and a rhodamine-labeled anti-mouse Ig were used
simultaneously. After three5-min washes inPBS, slidesforimmunofluores-
cence were mounted in 70% glycerol in PBS and peroxidase slides were
incubated with diaminobenzidine substrate. Immunofluorescence slides
were examined with a Leitz (Leica) epifluorescence photomicroscope with
appropriate filters and photographedforafixedtime (60 s) using KodakTri-
X Pan film.
Results
19 mAbs raised against the DMDL protein were screened
for specificity by Western blotting and immunohistochemis-
try on muscle sections (Table I). Nine of the antibodies
(MANCHOl1-19) were found to cross-react with dystrophin
and this is consistent with our earlier observation that poly-
clonal mouse antisera raised against the same lacZ-Bfm3 fu-
sion protein cross-react with dystrophin (11). On Western
blots, the 10 DMDL-specific mAbs (MANCH01-10) bind to
a 400K protein in both normal and mdx muscle and, in
characteristically larger amounts, in both normal and mdx
lung (Fig. 1); our previous results with polyclonal antisera
have shown that mdx lung expresses more DMDL protein
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Table L Characterization of19 mAbs against
the COOH-terminal Region ofthe Chromosome 6
Homologue of Human Dysrophin
" Only MANCHO11-19cross-reacted with thecorresponding region ofdystro-
phin in a fusion protein on ELISA plates and they also gave typical dystrophin
membrane staining (Dys) on frozen human muscle sections.
t All antibodies reacted with a 400K homologue band on Western blots of hu-
man lung and mdx mouse lung, though with different intensities.
§ Antibodies were tested for neuromuscular junction staining as in Fig. 2.
II Antibodies were placed in seven different epitope mapping groups from their
binding to different subfragments of the DMDL fusion protein (manuscript in
reparation; see refs 8, 12, 13).
Antibodies were tested forstaining of Duchenne sarcolemma as in Fig. 3. w,
weak.
than mdx muscle (11) . Dystrophin, in contrast, is found in
large amounts in normal muscle and in smaller amounts in
normal lung, but is absent from mdx tissues (Fig. 1). Both
dystrophin-specific and cross-reactive antibodies show char-
acteristic sarcolemmal immunostaining of normal human
and mouse frozen muscle sections, but DMDL-specific anti-
bodies do not stain normal muscle sarcolemma (Figs. 2 and
3). These results show the specificity of the mAbs for their
respective antigens in both SDS-denatured and native states.
Fardeau et al. (4) reported material cross-reacting with an-
tidystrophin antibodies at neuromuscular junctions in mdx
mouse muscle. We therefore examined sections of short
intercostal muscles which are relatively rich in neuromuscu-
lar junctions. We used double labeling with a rhodamine-
labeled anti-mouse Ig antibody in the presence of fluores-
cein-labeled a-bungarotoxin to locate both DMDL protein
and acetylcholine receptors in the same transverse sections
of intercostal muscle. Fig. 2 shows that DMDL-specific
mAb binding is localized near acetylcholine receptors at
neuromuscular junctions on the membranes of both normal
and mdx muscle fibers. In normal mouse muscle, the dystro-
phin-specific antibody, MANDYSI, bindsto the sarcolemma
with more intense labeling at the neuromuscular junctions,
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Antibody Subtype
Homologue-specific
Dys'
Lung*
Blot NMJ§ Groupll
DMD1
membrane
MANCHOI GI - ++ ND 4 +
MANCH02 GI - + ND 4 ND
MANCH03 Gl - ++ + 4 ND
MANCH04 G1 - + w 4 -
MANCH05 G1 - + ND 4 ND
MANCH06 GI - + + 4 ND
MANCH07 G2a - + + 5 +
MANCH08 G2a - ++ + 5 +
MANCH09 G2a - w w 5 +
MANCH010 G2a - + + 2 +
Cross-reactive with dystrophin
MANCHO1I Gl + ++ + 3 ND
MANCH012 Gl + + + 3 +
MANCH013 GI + w + 3 ND
MANCH014 Gl + ++ + 3 ND
MANCH015 G1 + + ND 6 +
MANCH016 G3 + + - 6 ND
MANCH017 G2a + + + + 6 +
MANCH018 Gl + ++ - 7
MANCH019 GI + + + 1 NDFigure 1. Western blots of
DMDL protein and dystro-
phin (DYS) in normal and
mdx mouse lung and muscle
extracts . The blots were incu-
bated with MANCH07 anti-
body for DMDL protein and
MANDYS1 for dystrophin.
We have optimized this meth-
od for detection of the low
levels ofDMDL protein in muscle and, consequently, the dystro-
phin band in normal muscle appears overloaded and distorted . The
smaller band at ti180kD is a degradation product of dystrophin .
MANCH07 is among the weaker of the DMDL-specific mono-
clonals on Western blots of SDS-denatured proteins (Table I and
Fig . 5), but is shown because it reacts well with native DMDL
protein on frozen sections and was used in Figs . 2-4 for this
reason .
but shows no binding tomdx muscle (since dystrophin is ab-
sent in mdx) . Other mAbs that recognize five additional
DMDL epitopes also showed neuromuscularjunction stain-
ing in mdx muscle (Table 1) . T\vo mAbs (MANCHO16 and
18) failed to stain neuromuscular junctions because they re-
quire denaturedDMDL antigen and so bind on Westernblots
but not frozen sections .
Fig . 3 shows that in human thigh muscle (where neuro-
muscular junctions are uncommon) DMDL-specific mAbs
show little or no detectable staining of the sarcolemma of
normal fibers, but they do show significant membrane stain-
ing on a large proportion of fibers from Duchenne patients .
The situation is the reverse of that seen with antidystrophin
antibodies, which stain normal but not Duchenne muscle
(Fig. 3) . Although the extent and intensity of staining varied
between fibers, at least50-80% of Duchenne fibers showed
some membrane staining withanti-DMDL antibodies, com-
pared with the verymuch smaller proportion of dystrophin-
positive fibers (1-3%) frequently reported in Duchenne pa-
tients . This result has been obtained with antibodies in five
epitope groups tested on three different Duchenne patients .
Sarcolemmal staining ofDMDL protein is also detectable in
mdx muscle (Fig. 2), even though background staining is
higher on mouse than on human sections. One antibody,
MANCHO4, which was negative on Duchenne membranes,
was also weak on neuromuscular junctions and is probably
too weak to detect low antigen levels (Table I) . It is not un-
common formAbs toshow a strong preference for either na-
tive or denatured antigen .
Figure 2 . Immunolocalization of DMDL protein and dystrophin (DYS) with acetylcholine receptors in normal and rndx mouse muscle
sections by double labeling . MANCH07 antibody for DMDL andMANDYSI for dystrophin were used, followed by a mixture of rhoda-
mine-labeled rabbit anti-(mouse Ig) and fluorescein-labeled a-bungarotoxin .
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1697Fig. 4 shows the localization ofDMDL protein in human
uterus sections using the homologue-specific antibody,
MANCH07, and illustrates both the intense staining of vas-
cular smooth muscle in blood vessels and the rather less
intense staining of bands of myometrial smooth muscle
throughout the surrounding tissue (Fig. 4 a) . At lower mag-
nification (Fig. 4 c), it is clear that each of these sites makes
a significant contribution to the totalDMDL protein content
of this tissue . We have observed similar binding ofDMDL-
specific antibodies to blood vessels in other tissues, includ-
ing lung, heart, liver, brain, and testis (results not shown) .
Fig . 5 a shows that a 400K protein comigrating with dys-
trophin can be detected by all anti=DMDL protein antibodies
tested on Western blots ofextracts ofproliferating tumor cell
lines ofboth gliai and Schwann cell origin . Variation in in-
tensity ofthe400K bandprobably reflects differences in anti-
body affinity for SDS-denatured DMDL protein, since - it
correlates well with intensity of staining of the human lung
400-kD protein by the same antibodies ('Fable I), notably the
weak reaction ofMANCH09 in lane 12 . These differences
make it difficult to obtain an absolute value for the ratio of
DMDL protein to dystrophin . It is clear, however, that the
ratio ofDMDL protein to dystrophin is'much higher in the
cell lines than in adult brain tissue, when Western blots of
the same samples are compared using dystrophin-specific
MANDYSI and DMDL-specific MANCH01 (Fig . 5 a,
lanes 2 and 9, and Fig . 5 b) . The subcellular localization of
DMDL protein in these cultured cells has not yet been deter-
mined, because of technical problems arising from their
small size and rounded morphology.
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Discussion
Figure 3 Immunolocalization
ofDMDL protein and dystro-
phin in normal and Duchenne
human muscle sections. Anti-
bodies and conditions as in
Fig. 2, except that a fluores-
cein-labeled anti-(mouse Ig)
was used . Duchenne biopsies
were taken from boys of4-6 yr
for the purpose of confirma-
tion of clinical diagnosis and
dystrophin was undetectable
usingboth rod andCOOH-ter-
minal antidystrophin antibodies.
We have shown that several different mAbs against the 400-
kD autosomal homologue ofdystrophin localize this protein
to the neuromuscular junction and to smooth muscle . The
latter observation explains our recent demonstration that
lung has high levels ofDMDL protein, relative to other tis-
sues, and that high levels ofDMDL transcripts are found in
placenta (11) . It remains to be seen whether all highly vascu-
lar tissues contain high levels ofthe homologue, but its pres-
ence in tissue culture cells (Fig. 5) shows that it is not merely
a smooth muscle isoform of dystrophin. Nevertheless, the
uniform staining of myometrial smooth muscle cells in
uterus (Fig . 4) contrasts strongly with the absence of staining
in skeletal muscle fibers (Fig . 3), except at neuromuscular
junctions . Both DMDL protein and dystrophin itself are
present at neuromuscular junctions (Fig . 2) . Pons et al . (14)
have described neuromuscular junction staining inmdx and
Duchenne skeletal muscle by antibodies raised against the
COON-terminal region of dystrophin and have suggested
that cross-reaction with a dystrophin-like protein is responsi-
ble . Our neuromuscular junction staining using several
mAbs raised against DMDL sequences provides direct evi-
dence that the antigen involved is an authentic product of the
DMDL gene, as opposed to indirect evidence obtained using
cross-reactive antidystrophin antibodies .
The DMDL-specific mAbs do not stain nonjunctional
membranes of normal human muscle, but they do stain
Duchenne membranes, though rather weakly . Similar results
have been obtained by 'Ianaka et al . (16, 17) . They raised a
1698Figure 4. Immunolocalization of DMDL protein in acetone-fixed sections of human uterus . In a and c, the mAb MANCHC 7 was used
as in Fig . 2, except that the detection system was a peroxidase-labeled anti-(mouse Ig) with DAB substrate. The control section (b) was
incubated with culture medium without antibody. Sections were counterstained with haemotoxylin to reveal nuclei . Binding to a large
blood vessel is visible in the center left of a, while areas of myometrial smooth muscle staining occupy much of the rest of this frame .
The overall extent of myometrial staining can be seen in the lower power micrograph (c) .
polyclonal antiserum against a 51 amino-acid synthetic pep-
tide near theCOOH terminus of the DMDL homologue and
observed weak staining of normal muscle membranes, but
much more intense staining of Duchenne and mdx mouse
membranes . These authors point out that, although the
DMDL protein is likely to be responsible, the possibility of
cross-reaction by other proteins that share an epitope with
DMDL protein cannotbe ruled out . Antibodies (monoclonal
or polyclonal) may cross-react with epitope-sharing proteins
on immunostained sections, even though they do not cross-
react on Western blots, and vice versa . A polyclonal antise-
rum raised against dystrophin, for example, has been shown
to stain both dystrophin and actinin in frozen sections,
though dystrophin was difficult to detect on Western blots
(6) . Without an available mutation resulting in absence ofthe
DMDL homologue (like the mdx and Duchenne mutations
for dystrophin), it is impossible to entirely rule out cross-
reactions with proteins other than DMDL and dystrophin .
mAbs against different epitopes on the DMDL protein, how-
ever, do resolve this problem to a considerable extent and the
fact that anumber ofdifferentmAbs bind to the neuromuscu-
Man et al . Localization ofDystrophin-related Protein
lar junction, vascular smooth muscle, the Duchenne mem-
brane, and transformed brain cell lines makes it more likely
that they are binding to authentic DMDL antigen at all four
locations . These data are a considerable advance on our ear-
lier studies (11) and those of Khurana et al . (7), in which
potentially cross-reactive polyclonal antisera against large
fragments of recombinant DMDL protein were used for
Western blotting .
There is evidence to suggest that there is more DMDL
mRNA and protein in fetal tissues than in adult tissues (7,
11) and several proteins associated with the neuromuscular
junction, including the acetylcholine receptor, have a more
general membrane distribution on immature, denervated, or
regenerating fibers (15) . Regenerating fibers might explain
the presence of DMDL-positive membranes in Duchenne
muscle (Fig . 3) . The high levels of DMDL protein in
proliferating brain cell tumor lines, relative to adult brain tis-
sue (Fig. 5), are also consistent with expression in prediffer-
entiation cells and tissues . Fetal tissues, however, may also
be more highly vasculated than adult tissues so that blood
vessels couldmake a significant contribution to fetalDMDL
1699Figure 5 . Presence ofDMDL protein and dystrophin (DYS) in ex-
tracts of (a) rat glioma and Schwannoma cultured tumor cells and
(b) adult mouse brainand muscle . (a) Extracts were subjected to
SDS-PAGE as a strip andthe Western blot wasdeveloped with 12
different mAbs applied in the "miniblotter" multiple lane blotting
apparatus. Two dystrophin-specific antibodies (lanes 1 and 2 ;
MANDYS16 andMANDYSI [12]), five DMDL-specific antibodies
(lanes 8-12 ; MANCHO 7, 1, 2, 3, and 9), and five antibodies that
bind bothDMDL and dystrophin (lanes 3-7 ; MANCHO 17, 15, 11,
18, and 19) were used . The intensity differences between glioma
and Schwannoma blots maybe accounted for by different total pro-
tein concentrations in thetwo extracts . (b) Identical amounts ofthe
same extracts of Balb/c mouse brainand muscle were used for the
two blots, whichwere developed with MANCHOI (lane 9 in a) for
DMDL and MANDYSI (lane2 in a) for dystrophin (DYS). As in
Fig . 1, when conditions are used that reveal the low levels of both
DMDL and dystrophin in adult brain, the dystrophin band in adult
muscle appears overloaded and distorted.
proteinandmRNA levels insome tissues . In dystrophic mus-
cle, thehomologuemay be occupying some ofthemembrane
sites left vacant by theabsenceofdystrophin . This raises the
intriguing question of whether the homologue can perform
any dystrophin-likefunctions at the muscle membrane. The
immunohistochemical analysis ofthe developmental expres-
sion of the DMDL protein and identification of proteins
with which it interacts should provide some insight into its
function .
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